These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34415177)

  • 1. Small Endogeneous Peptide Mitigates Myocardial Remodeling in a Mouse Model of Cardioselective Galectin-3 Overexpression.
    Sonkawade SD; Pokharel S; Karthikeyan B; Kim M; Xu S; Kc K; Sexton S; Catalfamo K; Spernyak JA; Sharma UC
    Circ Heart Fail; 2021 Sep; 14(9):e008510. PubMed ID: 34415177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
    Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model.
    Vlachou F; Varela A; Stathopoulou K; Ntatsoulis K; Synolaki E; Pratsinis H; Kletsas D; Sideras P; Davos CH; Capetanaki Y; Psarras S
    Cell Mol Life Sci; 2022 Apr; 79(5):250. PubMed ID: 35441327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
    Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
    Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
    Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
    Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 Is Associated with Cardiac Fibrosis and an Increased Risk of Sudden Death.
    Sherpa MD; Sonkawade SD; Jonnala V; Pokharel S; Khazaeli M; Yatsynovich Y; Kalot MA; Weil BR; Canty JM; Sharma UC
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174619
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Peng H; Xu J; Yang XP; Kassem KM; Rhaleb IA; Peterson E; Rhaleb NE
    Can J Physiol Pharmacol; 2019 Aug; 97(8):753-765. PubMed ID: 30998852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy.
    Sharma UC; Sonkawade SD; Spernyak JA; Sexton S; Nguyen J; Dahal S; Attwood KM; Singh AK; van Berlo JH; Pokharel S
    Circ Heart Fail; 2018 Aug; 11(8):e004867. PubMed ID: 30354563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis.
    Frunza O; Russo I; Saxena A; Shinde AV; Humeres C; Hanif W; Rai V; Su Y; Frangogiannis NG
    Am J Pathol; 2016 May; 186(5):1114-27. PubMed ID: 26948424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Deletion of Galectin-3 Exacerbates Age-Related Myocardial Hypertrophy and Fibrosis in Mice.
    Fontana Estevez FS; Betazza MC; Miksztowicz V; Seropian IM; Silva MG; Penas F; Touceda V; Selser C; Villaverde A; Goren N; Cianciulli TF; Medina V; Morales C; Gironacci M; González GE
    Cell Physiol Biochem; 2022 Aug; 56(4):353-366. PubMed ID: 35959709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction.
    Peng H; Sarwar Z; Yang XP; Peterson EL; Xu J; Janic B; Rhaleb N; Carretero OA; Rhaleb NE
    Hypertension; 2015 Sep; 66(3):582-9. PubMed ID: 26195478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of adverse remodelling by osteopontin in a genetic heart failure model.
    Psarras S; Mavroidis M; Sanoudou D; Davos CH; Xanthou G; Varela AE; Panoutsakopoulou V; Capetanaki Y
    Eur Heart J; 2012 Aug; 33(15):1954-63. PubMed ID: 21525025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.
    Martínez-Martínez E; Brugnolaro C; Ibarrola J; Ravassa S; Buonafine M; López B; Fernández-Celis A; Querejeta R; Santamaria E; Fernández-Irigoyen J; Rábago G; Moreno MU; Jaisser F; Díez J; González A; López-Andrés N
    Hypertension; 2019 Mar; 73(3):602-611. PubMed ID: 30612490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling.
    Zhao RR; Ackers-Johnson M; Stenzig J; Chen C; Ding T; Zhou Y; Wang P; Ng SL; Li PY; Teo G; Rudd PM; Fawcett JW; Foo RSY
    Circulation; 2018 Jun; 137(23):2497-2513. PubMed ID: 29371215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalizing biomarker strategies in heart failure with galectin-3.
    Sherwi N; Merali S; Wong K
    Future Cardiol; 2012 Nov; 8(6):885-94. PubMed ID: 23176690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
    Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
    J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of tanshinone II A inhibiting myocardial remodeling by Galectin-3].
    Zhang M; Cheng K; Yu L; Wu W; Wang Y; Chen Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):640-645. PubMed ID: 35924522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
    Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
    Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
    Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide riboside kinase-2 alleviates ischemia-induced heart failure through P38 signaling.
    Ahmad F; Tomar D; Aryal A C S; Elmoselhi AB; Thomas M; Elrod JW; Tilley DG; Force T
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165609. PubMed ID: 31743747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.